UnitedHealth Group Inc.

UNH

US91324P1021

Managed Healthcare

Market Closed - Nyse Other stock markets 21:00:02 17/07/2024 BST			5-day change	1st Jan Change
573.3 ^USD	+4.45%		+14.44%	+8.89%

07-17	UnitedHealth Selected to Continue Serving Medicaid Members in Rhode Island	MT
07-17	Nasdaq plunges, hit by tumbling chips, megacaps; Dow extends rally	RE

UnitedHealth Group Incorporated Affirms Earnings Guidance for the Year 2020

January 15, 2020 at 11:20 am

UnitedHealth Group Incorporated affirmed earnings guidance for the year 2020. The Company affirmed its recently issued full year earnings outlook for 2020, including net earnings of $15.45 to $15.75 per share.

Latest news about UnitedHealth Group Inc.

UnitedHealth Selected to Continue Serving Medicaid Members in Rhode Island	07-17	MT
Nasdaq plunges, hit by tumbling chips, megacaps; Dow extends rally	07-17	RE
Megacap tech, chip stock rout drags Nasdaq to two-week low; Dow outperforms	07-17	RE
UnitedHealth's Medical Loss Ratio Miss in Q2 Was Anticipated But Management 'Remains Diligent on Costs,' Morgan Stanley Says	07-17	MT
Stocks to watch as Biden, Trump vie for presidency	07-17	RE
Earnings reports take center stage as tech stocks tumble	07-17
Piper Sandler Raises Price Target on UnitedHealth to $605 From $571, Overweight Rating Maintained	07-17	MT
HSBC Adjusts UnitedHealth Group's PT to $610 From $580	07-17	MT
Argus Adjusts Price Target on UnitedHealth to $600 From $570	07-17	MT
TD Cowen Adjusts Price Target on UnitedHealth Group to $601 From $546, Maintains Buy Rating	07-17	MT
Goldman Sachs Adjusts Price Target on UnitedHealth Group to $642 From $596, Maintains Buy Rating	07-17	MT
Baird Adjusts Price Target on UnitedHealth Group to $640 From $597, Maintains Outperform Rating	07-17	MT
Leerink Partners Adjusts Price Target on UnitedHealth Group to $620 From $560, Maintains Outperform Rating	07-17	MT
Stephens Adjusts Price Target on UnitedHealth Group to $600 From $565, Maintains Overweight Rating	07-17	MT
Wells Fargo Adjusts Price Target on UnitedHealth Group to $630 From $525, Maintains Overweight Rating	07-17	MT
Barclays Adjusts Price Target on UnitedHealth Group to $604 From $560, Maintains Overweight Rating	07-17	MT
Truist Securities Adjusts Price Target on UnitedHealth Group to $640 From $600	07-17	MT
Morgan Stanley Raises Price Target on UnitedHealth Group to $615 From $595, Keeps Overweight Rating	07-17	MT
RBC Raises Price Target on UnitedHealth Group to $615 From $555, Keeps Outperform Rating	07-17	MT
Elevance beats profit estimates on lower-than-expected medical costs	07-17	RE
Elevance Health beats quarterly profit estimates	07-17	RE
Jefferies Upgrades UnitedHealth to Buy From Hold, Adjusts Price Target to $647 From $481	07-17	MT
Bernstein Adjusts Price Target on UnitedHealth to $654 From $635, Keeps Outperform Rating	07-17	MT
ANALYST RECOMMENDATIONS : American Airlines, Chevron, UnitedHealth, Bank of America, Eli Lilly...	07-17
Dow notches all-time high, small caps surge again	07-16	RE

Chart UnitedHealth Group Inc.

Duration

Period

More charts

Company Profile

UnitedHealth Group Inc. is one of the leading American suppliers of healthcare products and services. Income breaks down by activity as follows: - health insurance (57.4%; UnitedHealthcare); - prescription insurance plan management services (39.3%; Optum Health and Optum Rx): administrative management (reimbursement management, patient claim processing, etc.), drug distribution, decision-making information, sales of medical information management services, etc.; - provision of computer services (3.3%; Optum Insight): consulting, development, and integration of solutions for transaction management, healthcare plan management, data processing, etc.

Sector

Managed Healthcare

Calendar

14/10/2024 - Q3 2024 Earnings Release (Projected)

Related indices

Dow Jones Industrial , S&P 500

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

UnitedHealth Group confirms targets

July 16, 2024 at 02:28 pm

More Strategies

Ratings for UnitedHealth Group Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

573.3 USD

Average target price

608.1 USD

Spread / Average Target

+6.07%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Managed Healthcare

	1st Jan change	Capi.
UNITEDHEALTH GROUP INC.	+8.89%	505B
CIGNA	+15.13%	96.5B
HUMANA INC.	-12.15%	47.67B
CENTENE CORPORATION	-8.64%	36.88B
MOLINA HEALTHCARE, INC.	-17.49%	18.01B
PROGYNY, INC.	-20.44%	2.86B
ALIGNMENT HEALTHCARE, INC.	+16.14%	1.89B
CLOVER HEALTH INVESTMENTS, CORP.	+80.65%	859M

Other Managed Healthcare